Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: Using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin

Diabetic Medicine

Volumn 13, Issue 7, 1996, Pages 625-629

  Heinemann, L ^a   Heise, T ^a   Wahl, L Ch ^a   Trautmann, M E ^b   Ampudia, J ^a   Starke, A A R ^a   Berger, M ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Eli Lilly Deutschland   (Germany)

Author keywords

Fat absorbable carbohydrates; Insulin analogues; Insulin dependent diabetic patients; Prandial glycaemia

Indexed keywords

HUMAN INSULIN; INSULIN LISPRO; ISOPHANE INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIETARY CARBOHYDRATES; DOUBLE-BLIND METHOD; EATING; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PATIENT COMPLIANCE; TIME FACTORS;

EID: 0030055378     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199607)13:7<625::AID-DIA134>3.0.CO;2-2     Document Type: Article

References (16)

1. Berger M, Mühlhauser I. Implementation of intensified insulin therapy, a European perspective. Diabetic Med 1995; 12: 201-208.
2. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR. [Lys(B28), Pro(B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 1994; 43: 396-402.
3. Torlone E, Fanelli C, Rambotti AM, Kassi G, Modarelli F, Di Vincenzo A, et al. Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28, Pro(B29)] in IDDM. Diabetologia 1994; 37: 713-720.
4. Heinemann L, Heise T, Jorgensen LN, Starke AAR. Action profile of the rapid acting insulin analogue B28Asp. Diabetic Med 1993, 10: 535-539.
5. Hanning I, Home PD, Alberti KGMM. Measurement of free insulin concentrations: the influence of the timing of extraction of insulin antibodies. Diabetologia 1985; 28: 831-835.
6. Lean MEJ, Ng LL, Tennison BR. Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. Br Med J 1985; 290: 105-108.
7. Jorgensen LN, Nielsen FS. Timing of pre-meal insulins in diabetic patients on a multiple daily injection regimen. A questionaire study. Diabetologia 1990; 33 (suppl 1): A116.
8. Berger M, Cuppers HJ, Hegner H, Jörgens V, Berchtold P. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care 1982; 5: 77-91.
9. Sonnenberg CE, Kemmer FW, Berger M. Exercise in type 1 (insulin-dependent) diabetic patients treated with continuous subcutaneous insulin infusion. Prevention of exercise induced hypoglycaemia. Diabetologia 1990, 33: 696-703.
10. Heinemann L, Hohmann A, Starke AAR, Berger M. What is the correct timing of subcutaneous injections of regular insulin to cover carbohydrate rich meals? Horm Metab Res 1992; 26 (suppl): 137-139.
11. Berger M, Jörgens V. Praxis der Insulintherapie, 1st edn and 5th edn; Berlin, Springer-Verlag, 1982, 1995.
12. Kang S, Owens DR, Vora JP, Brange J. Comparison of insulin analogue B9AspB27Glu and soluble human insulin in insulin-treated diabetes. Lancet 1990; 335: 303-306.
13. B28) on meal-related plasma glucose excursions in type I diabetic subjects. Diabetes Care 1991; 14: 571-577.
14. Tuominen JA, Karonen SL, Melamies L, Bolli G, Koivisto VA. Exercise induced hypoglycaemia in IDDM patients treated with a short acting insulin analogue. Diabetologia 1995; 38: 106-111.
15. Ahern JA, Gatcomb PM, Held NA, Petit WA, Tamborlane WV. Exaggerated hyperglycemia after a pizza meal in well-controlled diabetes. Diabetes Care 1993, 16: 578-580.
16. Berger M, Heinemann L. Are presently available insulin analogues clinically beneficial? Diabetologia 39 (suppl) 1996; (in press).